Technion professor Dr. Izhak Kehat recently went to Long Beach Island to talk to American Technion Society supporters and community members about the state of medicine in Israel, and about work to modify genes to repair failing hearts. His goal is reducing heart attacks — the leading cause of death worldwide. Dr. Kehat, who also is a senior cardiologist at the Rambam Medical Center, says that cardiovascular disease is rising because the treatments that address heart disease’s common causes — hypertension, high blood pressure, leaky valves, and more — extend life for a time, but they do not address the disease’s root cause.
Dr. Kehat’s lab — the Molecular Cardiovascular System Research Lab, which is within the Technion’s Ruth and Bruce Rappaport Faculty of Medicine — focuses on the molecular mechanisms responsible for the abnormal enlargement of the heart during cardiac failure. Its goal it to translate those findings into state-of-the-art therapies that could reduce heart disease-related deaths.